BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21620943)

  • 1. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.
    Sacco E; Metalli D; Spinelli M; Manzoni R; Samalikova M; Grandori R; Morrione A; Traversa S; Alberghina L; Vanoni M
    Biotechnol Adv; 2012; 30(1):233-43. PubMed ID: 21620943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.
    Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L
    Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
    Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
    Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isolated catalytic hairpin of the Ras-specific guanine nucleotide exchange factor Cdc25Mm retains nucleotide dissociation activity but has impaired nucleotide exchange activity.
    Sacco E; Fantinato S; Manzoni R; Metalli D; De Gioia L; Fantucci P; Alberghina L; Vanoni M
    FEBS Lett; 2005 Dec; 579(30):6851-8. PubMed ID: 16325815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
    Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
    Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
    Yoshikawa T; Sugita T; Mukai Y; Abe Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Jul; 30(19):3318-23. PubMed ID: 19304319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
    Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
    Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells.
    Chen G; Da L; Wang H; Xu Y; Chen G; Sun C; Wang L; Zhao J; Zhang F; Feng J; Wang Y; Tiollais P; Li T; Zhao M
    Gastroenterology; 2011 Jan; 140(1):332-43. PubMed ID: 20816839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure determination and dynamics of peptides overlapping the catalytic hairpin of the Ras-specific GEF Cdc25(Mm).
    Consonni R; Arosio I; Recca T; Longhi R; Colombo G; Vanoni M
    Biochemistry; 2003 Oct; 42(42):12154-62. PubMed ID: 14567676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant cell-permeable p53 fusion protein is selectively stabilized under hypoxia and inhibits tumor cell growth.
    Yu Z; Wu J; Wu S; Jia P; Tong Y; Wu X; Wang Y
    Cancer Lett; 2009 Jun; 279(1):101-7. PubMed ID: 19232460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
    Harada H; Hiraoka M; Kizaka-Kondoh S
    Cancer Res; 2002 Apr; 62(7):2013-8. PubMed ID: 11929818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B; To R; Stayton PS
    Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired glucose sensitivity of k-ras transformed fibroblasts.
    Chiaradonna F; Magnani C; Sacco E; Manzoni R; Alberghina L; Vanoni M
    Biochem Soc Trans; 2005 Feb; 33(Pt 1):297-9. PubMed ID: 15667331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice.
    Brabant M; Baux L; Casimir R; Briand JP; Chaloin O; Porceddu M; Buron N; Chauvier D; Lassalle M; Lecoeur H; Langonné A; Dupont S; Déas O; Brenner C; Rebouillat D; Muller S; Borgne-Sanchez A; Jacotot E
    Apoptosis; 2009 Oct; 14(10):1190-203. PubMed ID: 19693674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of ESX1 on cancer cells harboring oncogenic K-ras mutation.
    Nakajima J; Ishikawa S; Hamada J; Yanagihara M; Koike T; Hatakeyama M
    Biochem Biophys Res Commun; 2008 May; 370(1):189-94. PubMed ID: 18361917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.
    Sugita T; Yoshikawa T; Mukai Y; Yamanada N; Imai S; Nagano K; Yoshida Y; Shibata H; Yoshioka Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
    Biochem Biophys Res Commun; 2007 Nov; 363(4):1027-32. PubMed ID: 17923117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4.
    Wang H; Chen X; Chen Y; Sun L; Li G; Zhai M; Zhai W; Kang Q; Gao Y; Qi Y
    Amino Acids; 2013 Feb; 44(2):499-510. PubMed ID: 22802137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
    Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
    J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.